Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
QuintilesIMS
US Army
McKinsey
Argus Health
Teva
Cipla
Covington

Generated: August 18, 2018

DrugPatentWatch Database Preview

Sunovion Resp Company Profile

« Back to Dashboard

What is the competitive landscape for SUNOVION RESP, and when can generic versions of SUNOVION RESP drugs launch?

SUNOVION RESP has one approved drug.

There are nine US patents protecting SUNOVION RESP drugs.

There are sixty-five patent family members on SUNOVION RESP drugs in thirteen countries.

Summary for Sunovion Resp
International Patents:65
US Patents:9
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Sunovion Resp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 9,789,270 ➤ Sign Up Y ➤ Sign Up
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 9,265,900 ➤ Sign Up Y ➤ Sign Up
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 9,604,018 ➤ Sign Up Y ➤ Sign Up
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 8,511,581 ➤ Sign Up Y ➤ Sign Up
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 6,962,151 ➤ Sign Up Y ➤ Sign Up
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 7,316,067 ➤ Sign Up Y ➤ Sign Up
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 7,931,212 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Sunovion Resp Drugs

Country Document Number Estimated Expiration
Austria 453424 ➤ Sign Up
Australia 1234801 ➤ Sign Up
European Patent Office 1919542 ➤ Sign Up
European Patent Office 2437896 ➤ Sign Up
World Intellectual Property Organization (WIPO) 2007020073 ➤ Sign Up
European Patent Office 2062608 ➤ Sign Up
Japan 4787307 ➤ Sign Up
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Mallinckrodt
Federal Trade Commission
Farmers Insurance
Boehringer Ingelheim
Fuji
US Army
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.